Vedel P, Obel J, Nielsen F S, Bang L E, Svendsen T L, Pedersen O B, Parving H H
Steno Diabetes Center, Gentofte, Denmark.
Diabetologia. 1996 Dec;39(12):1584-9. doi: 10.1007/s001250050618.
Glomerular hyperfiltration and microalbuminuria are both regarded as risk factors for the development of diabetic nephropathy in insulin-dependent diabetic patients. Information on glomerular hyperfiltration is scarce in microalbuminuric non-insulin-dependent diabetic (NIDDM) patients. Therefore, we performed a cross-sectional study of glomerular filtration rate (single i.v. bolus injection of 51Cr-EDTA, plasma clearance for 4 h) in 158 microalbuminuric NIDDM patients compared to 39 normoalbuminuric NIDDM patients and 20 non-diabetic control subjects. The groups were well-matched with regard to sex, age and body mass index. The uncorrected (ml/min) and the adjusted (ml. min-1. 1.73 m-2) glomerular filtration rate were both clearly elevated in the microalbuminuric patients: 139 +/- 29 and 117 +/- 24 as compared to 115 +/- 19 and 99 +/- 15; 111 +/- 23 and 98 +/- 21 in normoalbuminuric NIDDM patients and control subjects, respectively (p < 0.001). The glomerular filtration rate (ml. min-1. 1.73 m-2) in NIDDM patients who had never received antihypertensive treatment was also clearly elevated in the microalbuminuric patients (n = 96): 119 +/- 22 as compared to 100 +/- 14 and 98 +/- 21 in normoalbuminuric NIDDM patients (n = 27) and control subjects (n = 20), respectively (p < 0.001). Glomerular hyperfiltration (elevation above mean glomerular filtration rate plus 2 SD in normoalbuminuric NIDDM patients) was demonstrated in 37 (95% confidence interval 30-45)% of the microalbuminuric patients. Multiple regression analysis revealed that HbA1c, 24-h urinary sodium excretion, age and known duration of diabetes were correlated with glomerular filtration rate in microalbuminuric NIDDM patients (r2 = 0.21, p < 0.01). Our cross-sectional study indicates that NIDDM patients at high risk of developing diabetic nephropathy are also characterized by an additional putative risk factor for progression, glomerular hyperfiltration.
肾小球高滤过和微量白蛋白尿均被视为胰岛素依赖型糖尿病患者发生糖尿病肾病的危险因素。关于微量白蛋白尿的非胰岛素依赖型糖尿病(NIDDM)患者的肾小球高滤过信息较少。因此,我们对158例微量白蛋白尿的NIDDM患者进行了一项关于肾小球滤过率的横断面研究(单次静脉推注51Cr - EDTA,4小时血浆清除率),并与39例正常白蛋白尿的NIDDM患者和20例非糖尿病对照者进行比较。这些组在性别、年龄和体重指数方面匹配良好。微量白蛋白尿患者的未校正(ml/min)和校正后(ml·min-1·1.73 m-2)肾小球滤过率均明显升高:分别为139±29和117±24,而正常白蛋白尿的NIDDM患者和对照者分别为115±19和99±15;111±23和98±21(p<0.001)。从未接受过抗高血压治疗的NIDDM患者中,微量白蛋白尿患者(n = 96)的肾小球滤过率(ml·min-1·1.73 m-2)也明显升高:分别为119±22,而正常白蛋白尿的NIDDM患者(n = 27)和对照者(n = 20)分别为100±14和98±21(p<0.001)。37%(95%置信区间30 - 45%)的微量白蛋白尿患者存在肾小球高滤过(高于正常白蛋白尿NIDDM患者平均肾小球滤过率加2个标准差)。多元回归分析显示,HbA1c、24小时尿钠排泄、年龄和已知糖尿病病程与微量白蛋白尿的NIDDM患者的肾小球滤过率相关(r2 = 0.21,p<0.01)。我们的横断面研究表明,有发生糖尿病肾病高风险的NIDDM患者还具有另一个进展的潜在危险因素,即肾小球高滤过。